Oddmund Nordgård

Professor II

University of Stavanger

Norway

Research Interests

Explore related searches

Professors in Norway Professors in Medical Imaging Medical Imaging professors in Norway

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor II Oddmund Nordgård is affiliated with the University of Stavanger in Norway. His research primarily focuses on liquid biopsies, particularly the monitoring of circulating tumor DNA and extracellular vesicles in various cancers, including breast and pancreatic cancer. Recent publications highlight his work on biomarkers for clinical outcomes in metastatic cancer patients and novel methods of ctDNA detection. His contributions aim to enhance the understanding of cancer progression and improve patient monitoring through innovative diagnostic approaches.

Articles (10)

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (6)

Rakel Brendsdal Forthun

Haukeland University Hospital

NORWAY

View details

Karl-Henning Kalland

Professor

University of Bergen

NORWAY

View details

Nina Egeland Amundsen

University of Stavanger

NORWAY

View details

Liv Thomsen

University of Bergen

NORWAY

View details

Nikolai Kragøe Andresen

Oslo University Hospital

NORWAY

View details

Birgitta Haga Gripsrud

Professor of Health Humanities and Psychosocial Studies

University of Stavanger

NORWAY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Oddmund Nordgård

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors – a biomarker analysis of the ALICE and ICON trials

Extracellular vesicles as a potential source of tumor-derived DNA in advanced pancreatic cancer

Monitoring of circulating tumour DNA in advanced pancreatic ductal adenocarcinoma predicts clinical outcome and reveals disease progression earlier than radiological imaging

Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progression in Advanced Pancreatic Cancer

Prognostic value of disseminated tumor cells in unresectable pancreatic ductal adenocarcinoma: a prospective observational study.

Liquid biopsies and patient-reported outcome measures for integrative monitoring of patients with early-stage breast cancer: a study protocol for the longitudinal observational Prospective Breast Cancer Biobanking (PBCB) study.

Novel hybridization- and tag-based error-corrected method for sensitive ctDNA mutation detection using ion semiconductor sequencing.

Platelet Microparticles Decrease Daunorubicin-Induced DNA Damage and Modulate Intrinsic Apoptosis in THP-1 Cells.

Liquid Biopsies in Solid Cancers: Implementation in a Nordic Healthcare System.

Platelet Microparticles Protect Acute Myelogenous Leukemia Cells against Daunorubicin-Induced Apoptosis.

Collaborators (6)

Rakel Brendsdal Forthun

Karl-Henning Kalland

Nina Egeland Amundsen

Liv Thomsen

Nikolai Kragøe Andresen

Birgitta Haga Gripsrud

Make your next move.